However, the combination of neratinib 240 mg OD with capecitabine 750 mg/m2 BID D1-D14 achieved more promising results in HER2-positive ABC with brain metastases and previous CNS-directed treatment. The gene discussed is ERBB2; the disease is aneurysmal bone cyst.